In vitro diagnostic medical devices (IVD)

In vitro diagnostic medical devices (IVD) must achieve the performance declared by the manufacturer, in particular, as appropriate, in terms of analytical sensitivity, diagnostic sensitivity, analytical specificity, diagnostic specificity, accuracy, repeatability, reproducibility, including the control of the known relevant interferences with other products, and with regard to the detection limit of the examined parameter.
The manufacturer demonstrates that these requirements are met by a combination of relevant scientific literature and performance studies. Depending on the type of IVD, the validation of this data is certified by a notified body or by self-certification.


Legislation applicable to medical devices used in clinical studies

Guidelines

Contact 

ct.rd@fagg.be

 

 

Performance studies to be notified and notification procedure

Amendments

Notification of termination of the Clinical Investigation

Last updated on 03/03/2021